This is a community-generated profile. If you would like to claim it, please .
Alkermes
Develops medicines for psychiatric and neurological disorders501-1000 EmployeesActively Hiring
Alkermes Funding
$250M
11 round
Alkermes is active in the following markets / industries: biotechnology. The company has secured funding across 1 rounds, totaling in an amount of $250M. Their most recent funding was raised on January 13, 2014.
Funding Rounds
U
$250000000Investments of Alkermes
Civitas Therapeutics
